Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Apperley

Showing results (51-60 of 117) with videos related to

Pageof 12
Sort By:
Haematologica|June 1, 2005
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trialNorbert Schmitz, Meral Beksac, Andrea Bacigalupo, et al.
Cytotherapy|October 12, 2013
Regulation of advanced therapy medicinal products in Europe and the role of academiaKim F Pearce, Martin Hildebrandt, Hildegard Greinix, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Defining the intensity of conditioning regimens: working definitionsAndrea Bacigalupo, Karen Ballen, Doug Rizzo, et al.
Clinical Chemistry|December 17, 2016
RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid LeukemiaMary Alikian, Alexandra S Whale, Susanna Akiki, et al.
The Journal of Molecular Diagnostics : JMD|February 10, 2016
Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia PatientsMary Alikian, Peter Ellery, Martin Forbes, et al.
Blood|November 16, 2002
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemiaAlois Gratwohl, Ronald Brand, Jane Apperley, et al.
Annals of the Rheumatic Diseases|September 5, 2006
Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literatureThomas Daikeler, Ina Kötter, Chiara Bocelli Tyndall, et al.
American Journal of Hematology|January 11, 2012
BCR-ABL1 kinase domain mutations: methodology and clinical evaluationMary Alikian, Gareth Gerrard, Papagudi G Subramanian, et al.
Haematologica|July 21, 2007
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized studyJean-Henri Bourhis, Yasmina Bouko, Serge Koscielny, et al.
Bone Marrow Transplantation|March 24, 2020
Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working PartyEolia Brissot, Myriam Labopin, Domenico Russo, et al.
Pageof 12

Showing results (51-60 of 117) with videos related to

Sort By:
Pageof 12
Haematologica|June 1, 2005
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trialNorbert Schmitz, Meral Beksac, Andrea Bacigalupo, et al.
Cytotherapy|October 12, 2013
Regulation of advanced therapy medicinal products in Europe and the role of academiaKim F Pearce, Martin Hildebrandt, Hildegard Greinix, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Defining the intensity of conditioning regimens: working definitionsAndrea Bacigalupo, Karen Ballen, Doug Rizzo, et al.
Clinical Chemistry|December 17, 2016
RT-qPCR and RT-Digital PCR: A Comparison of Different Platforms for the Evaluation of Residual Disease in Chronic Myeloid LeukemiaMary Alikian, Alexandra S Whale, Susanna Akiki, et al.
The Journal of Molecular Diagnostics : JMD|February 10, 2016
Next-Generation Sequencing-Assisted DNA-Based Digital PCR for a Personalized Approach to the Detection and Quantification of Residual Disease in Chronic Myeloid Leukemia PatientsMary Alikian, Peter Ellery, Martin Forbes, et al.
Blood|November 16, 2002
Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemiaAlois Gratwohl, Ronald Brand, Jane Apperley, et al.
Annals of the Rheumatic Diseases|September 5, 2006
Haematopoietic stem cell transplantation for vasculitis including Behcet's disease and polychondritis: a retrospective analysis of patients recorded in the European Bone Marrow Transplantation and European League Against Rheumatism databases and a review of the literatureThomas Daikeler, Ina Kötter, Chiara Bocelli Tyndall, et al.
American Journal of Hematology|January 11, 2012
BCR-ABL1 kinase domain mutations: methodology and clinical evaluationMary Alikian, Gareth Gerrard, Papagudi G Subramanian, et al.
Haematologica|July 21, 2007
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized studyJean-Henri Bourhis, Yasmina Bouko, Serge Koscielny, et al.
Bone Marrow Transplantation|March 24, 2020
Alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation in second complete remission: a report from the EBMT Acute Leukemia Working PartyEolia Brissot, Myriam Labopin, Domenico Russo, et al.
Pageof 12